Cutler Group LP Ionis Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 09, 2019	SELL	$62.09 - $86.14 $372,540 - $516,840	-6,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$52.92 - $81.17 $89,964 - $137,989	1,700 Added 39.53%	6,000 $8,000
Q3 2018 Nov 07, 2018	SELL	$42.88 - $53.7 $21,440 - $26,850	-500 Reduced 10.42%	4,300 $5,000
Q2 2018 Aug 10, 2018	SELL	$40.53 - $50.7 $251,286 - $314,340	-6,200 Reduced 56.36%	4,800 $19,000
Q1 2018 May 11, 2018	SELL	$44.08 - $55.05 $66,120 - $82,575	-1,500 Reduced 12.0%	11,000 $59,000
Q4 2017 Jan 17, 2018	SELL	$50.3 - $64.39 $880,250 - $1.13 Million	-17,500 Reduced 58.33%	12,500 $30,000
Q3 2017 Oct 17, 2017	BUY	$45.56 - $59.57 $1.37 Million - $1.79 Million	30,000	30,000 $130,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.